<DOC>
	<DOCNO>NCT02113254</DOCNO>
	<brief_summary>The Age Macular Degeneration ( AMD ) first cause blindness industrialized country . The macular pigment ( lutein zeaxanthin ) could play important role arisen AMD . The food supplementation corn strong concentration macular pigment could increase density macular pigment . This could , future , represent strategy prevention AMD . The main objective study detect increase macular pigment density consumption corn healthy volunteer .</brief_summary>
	<brief_title>Study Macular Pigment Consumption Corn With Strong Content Zeaxanthine</brief_title>
	<detailed_description>The age macular degeneration represent first cause blindness industrialized country treat . In France , AMD affect 600 000 person figure continue increase , notably increase life expectancy . The macula responsible fine vision , vision colour perception contrast . The macular pigment present level macular area . This pigment compose three carotenoid : lutein , zeaxanthin , meso-zeaxanthin . The first two compound strictly food origin produce endogenous way . A change macular pigment density and/or quality macular pigment suspect play role appearance evolution AMD . The food supplementation corn strong concentration macular pigment could increase density macular pigment . This could , future , represent strategy prevention AMD . The main objective study detect increase macular pigment density consumption corn healthy volunteer . The treatment consist daily consumption box 125g corn strong zeaxanthin content 10 week . This correspond daily contribution least 1,2 mg lutein 2,2 mg de zeaxanthin . After inclusion visit , subject see 5 time ( 3 , 6 , 8 , 10 , 14 week treatment ) . In visit , measure macular pigment realize . A blood sample realize inclusion visit visit 6 10 week .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Inclusion criterion : Healthy volunteer , men woman Corrected visual acuity upper equal 8/10 two eye . Age : 20 35 year Free write consent sign participant investigator examination require research Subject agree registered national file Affiliated subject national insurance scheme Exclusion criterion : Presence AMD sign one two eye Histories evolutionary ocular pathology susceptible complicate evaluation AMD visual acuity ( glaucoma , high myopia forte ( &gt; = 6 dioptre ) , strong retinopathy… ) Subject operate de cataract Lens Opacities ( NO &gt; =3 , et/ou NC &gt; =3 , et/ou C &gt; =1 et/ou P &gt; =1 accord LOCSII method ) Food complement year wich precedes ( list complement appendix 2 ) Hypersensitive people tropicamide , atropine , byproduct , one excipients tropicamide Patients risk angle closure glaucoma Body Masse Index &gt; = 30 kg/m2 Current smoking stop le 12 month Diabetes High blood pressure Hyperlipidemia Neuroinflammatory diseases Chronical gastrointestinal disease ( Crohn … ) Taking continuous medicine one month , last 12 month ( exception contraceptive pill ) Pregnant breastfeed woman Vegetarian Patient Participation another clinical trial 30 day wich precedes Not compliant subject Subject without french national insurance scheme Subject guardianship judicial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>corn</keyword>
	<keyword>macular pigment</keyword>
	<keyword>lutein</keyword>
	<keyword>zeaxanthin</keyword>
	<keyword>Age Macular Degeneration</keyword>
	<keyword>AMD</keyword>
</DOC>